GeoVax Labs, Inc. (GOVX) Key Metrics
GOVX valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $2.4M
- Enterprise value
- $15.1M
- P/E (TTM)
- —
- Forward P/E
- 9.7
- PEG ratio
- —
- Price / sales
- 4.4
- Price / book
- 5.8
- EV / EBITDA
- 15.3
- Dividend yield
- —
- Beta
- 3.69
GOVX key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsGOVX returns How much profit the business earns on the capital it uses.
Return on equity−21.5 pts
−483.8%
2025 · hover or tap a bar for each year
20162025
Return on assets−9.5 pts
−296.1%
2025 · hover or tap a bar for each year
20162025
Free cash flow margin−239.3 pts
−863.8%
2025 · hover or tap a bar for each year
20162025
Asset turnover−24.3%
0.34
2025 · hover or tap a bar for each year
20162025
GOVX financial health Debt, liquidity and how easily interest is covered.
Debt / equity
0.22
2025 · hover or tap a bar for each year
20162025
Net debt+$3.3M
−$2.2M
2025 · hover or tap a bar for each year
20162025
Current ratio+7.5%
2.74
2025 · hover or tap a bar for each year
20162025
Debt / assets
0.13
2025 · hover or tap a bar for each year
20162025
GOVX efficiency & capital use Working capital cycle and where the cash goes.
Days payables outstanding−8,877 days
27 days
2025 · hover or tap a bar for each year
20162025
Capex / revenue+0.6 pts
1.1%
2025 · hover or tap a bar for each year
20162025
GOVX valuation history
Fiscal year-endToday10-year median
GOVX returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
GOVX debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
GOVX cash returned to shareholders
DividendsBuybacksFree cash flow
GOVX price vs earnings per share
Share price at year-endEPS (right axis)
GOVX key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | — | $320.3M | — | — | — | — | — | — | — | — |
| Enterprise value | — | $314.8M | — | — | — | — | — | — | — | — |
| Price / sales | — | 81.0 | — | — | — | — | — | — | — | — |
| Price / book | — | 63.4 | — | — | — | — | — | — | — | — |
| EV / sales | — | 79.6 | — | — | — | — | — | — | — | — |
| Earnings yield | — | −7.8% | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | −7.7% | — | — | — | — | — | — | — | — |
| Share price at fiscal year-end | $4.28 | $61.75 | $135.38 | $236.32 | $1,357.50 | $1,267.50 | $4,500.00 | $1,000,000.01 | $1,000,000.01 | $1,000,000.01 |
| Per share | ||||||||||
| Revenue per share | — | $0.76 | — | — | — | — | — | — | — | — |
| Earnings per share | — | −$4.82 | — | — | — | — | — | — | — | — |
| Operating cash flow per share | — | −$4.76 | — | — | — | — | — | — | — | — |
| Free cash flow per share | — | −$4.76 | — | — | — | — | — | — | — | — |
| Cash per share | — | $1.06 | — | — | — | — | — | — | — | — |
| Book value per share | — | $0.97 | — | — | — | — | — | — | — | — |
| Tangible book value per share | — | $0.96 | — | — | — | — | — | — | — | — |
| Capex per share | — | $0.00 | — | — | — | — | — | — | — | — |
| Shares outstanding | — | 5.2M | — | — | — | — | — | — | — | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −483.8% | −462.3% | −160.5% | −90.5% | −266.0% | −73.5% | — | — | — | −452.8% |
| Return on assets (ROA) | −296.1% | −286.6% | −127.8% | −65.0% | −167.0% | −54.1% | −426.8% | −452.2% | −394.4% | −337.0% |
| Return on tangible assets | −341.2% | −308.7% | −281.8% | −44.8% | −157.1% | −28.3% | −505.6% | −398.8% | −442.7% | −536.2% |
| Free cash flow margin | −863.8% | −624.5% | — | — | — | −159.5% | −119.6% | −160.2% | −157.4% | — |
| Financial health | ||||||||||
| Total debt | $843,170 | — | — | — | — | $198,064 | $39,743 | $300,000 | — | — |
| Cash & short-term investments | $3.1M | $5.5M | $6.5M | $27.6M | $11.4M | $9.9M | $283,341 | $260,000 | $312,727 | $454,030 |
| Net debt | −$2.2M | −$5.5M | −$6.5M | −$27.6M | −$11.4M | −$9.7M | −$243,598 | $40,000 | −$312,727 | −$454,030 |
| Debt / equity | 0.22 | — | — | — | — | 0.02 | — | — | — | — |
| Debt / assets | 0.13 | — | — | — | — | 0.02 | 0.08 | 0.47 | — | — |
| Current ratio | 2.74 | 2.55 | 2.24 | 6.10 | 2.14 | 12.63 | 0.22 | 0.38 | 0.55 | 1.47 |
| Quick ratio | 2.74 | 2.55 | 2.24 | 6.10 | 2.15 | 12.86 | 0.22 | 0.46 | 0.55 | 1.47 |
| Interest coverage | — | — | — | -246.8 | — | -19.6 | -527.8 | -989.6 | — | — |
| Working capital | $3.4M | $4.8M | $4.4M | $24.2M | $6.2M | $9.4M | −$1.6M | −$1.0M | −$363,218 | $174,532 |
| Invested capital | $1.6M | −$458,406 | −$689,251 | −$1.0M | −$7.1M | −$116,936 | −$1.8M | −$982,000 | −$633,784 | −$213,660 |
| Tangible asset value | $3.8M | $5.0M | $5.7M | $26.5M | $4.4M | $9.6M | −$1.6M | −$1.0M | −$321,057 | $240,370 |
| Net current asset value | $2.8M | $4.8M | $4.4M | $24.2M | $4.2M | $9.4M | −$1.6M | −$1.0M | −$363,218 | $174,532 |
| Graham net-net per share | — | $0.56 | — | — | — | — | — | — | — | — |
| Capital allocation | ||||||||||
| Share buybacks (net) | — | — | — | $0 | $1,000 | $0 | $0 | $0 | $0 | $0 |
| Capex / revenue | 1.1% | 0.5% | — | 165.8% | 12.4% | 8.6% | 0.6% | 0.8% | 0.4% | 1,912.1% |
| Capex / depreciation | 0.40 | 0.22 | 0.66 | 2.39 | 1.24 | 7.98 | 0.91 | 0.38 | 0.16 | 550.73 |
| Stock-based compensation / revenue | 44.8% | 13.4% | — | 1,113.7% | 96.1% | 3.5% | 27.9% | 48.8% | 5.3% | 116.7% |
| R&D / revenue | 728.0% | 599.6% | — | 11,263.0% | 4,040.0% | 134.1% | 162.5% | 195.1% | 187.6% | 237.8% |
| SG&A / revenue | 241.3% | 136.2% | — | 6,156.8% | 929.1% | 120.5% | 139.3% | 171.0% | 114.6% | 257.1% |
| Efficiency | ||||||||||
| Days sales outstanding | — | 60.9 | — | — | 109.8 | 25.2 | 29.6 | 34.4 | 14.9 | 32.6 |
| Days of inventory on hand | — | — | — | — | -2.7 | -27.3 | — | -23.7 | — | — |
| Days payables outstanding | 26.6 | 8,903.6 | 40.1 | 12,338.4 | 27.3 | 31.4 | 26.6 | 19.8 | 13.9 | 16.3 |
| Cash conversion cycle (days) | — | -8,842.7 | — | — | 79.8 | -33.5 | 3.0 | -9.0 | 1.0 | 16.2 |
| Receivables turnover | — | 6.00 | — | — | 3.32 | 14.51 | 12.35 | 10.61 | 24.48 | 11.20 |
| Payables turnover | 13.73 | 0.04 | 9.11 | 0.03 | 13.38 | 11.63 | 13.72 | 18.47 | 26.34 | 22.33 |
| Asset turnover | 0.34 | 0.45 | 0.00 | 0.00 | 0.03 | 0.34 | 2.12 | 1.70 | 1.95 | 0.85 |
| Average receivables | — | $659,409 | — | — | $115,834 | $125,633 | $95,208 | $90,786 | $43,916 | $74,026 |
| Average payables | $1.3M | $2.3M | $2.3M | $1.9M | $1.2M | $210,178 | $139,256 | $101,720 | $76,594 | $88,271 |
| Average inventory | — | — | — | — | −$115,834 | −$182,663 | — | −$121,814 | — | — |
| Intangibles / total assets | 0.8% | 0.7% | 0.8% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from GOVX's annual financial statements (latest annual report filed April 15, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
GOVX valuation and financial ratios
GeoVax Labs earned a return on equity of −483.8% in fiscal 2025. It ended the year with $0.8 million of debt and $3.1 million in cash and short-term investments, a net cash position of $2.2 million.
See the GOVX income statement, the GOVX chart for price history, or the GOVX stock overview for the latest quote and news.
GOVX key metrics FAQ
What is GeoVax Labs's return on equity?
GeoVax Labs's return on equity (ROE) was −483.8% in fiscal 2025: net income of -$21.5 million on average shareholders' equity of $4.4 million.
How much debt does GeoVax Labs have?
GeoVax Labs had total debt of $0.8 million at the end of fiscal 2025, a debt-to-equity ratio of 0.22 and more cash than debt.
What is GeoVax Labs's current ratio?
GeoVax Labs's current ratio was 2.74 at the end of fiscal 2025: current assets were 2.74 times current liabilities.